🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for transformative discoveries that illuminate how the body's defense network targets harmful infections while sparing the body's own cells.

A trio of renowned researchers—Japan's Prof. Sakaguchi and US experts Mary Brunkow and Fred Ramsdell—share this honor.

Their work uncovered unique "security guards" within the immune system that eliminate rogue defense cells capable of attacking the organism.

These discoveries are now paving the way for innovative therapies for immune disorders and malignancies.

These winners will share a monetary award valued at 11 million SEK.

Crucial Findings

"Their research has been decisive for understanding how the immune system operates and why we do not all develop severe self-attack conditions," stated the chair of the award panel.

This team's research address a core question: In what way does the immune system defend us from countless infections while keeping our healthy cells intact?

The body's protection system employs white blood cells that scan for signs of infection, including pathogens and bacteria it has never encountered.

These defenders employ sensors—known as receptors—that are generated randomly in a vast number of variations.

That provides the immune system the capacity to combat a wide array of invaders, but the unpredictability of the process unavoidably creates white blood cells that may attack the body.

Protectors of the Immune System

Researchers earlier understood that some of these harmful white blood cells were destroyed in the immune organ—the site where immune cells mature.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—known as the immune system's "peacekeepers"—which travel through the system to disarm other defenders that attack the healthy cells.

We know that this mechanism fails in self-attack conditions such as juvenile diabetes, MS, and RA.

The Nobel panel added, "The findings have laid the foundation for a new field of research and accelerated the development of new therapies, for example for cancer and autoimmune diseases."

Regarding malignancies, T-regs block the system from fighting the growth, so research are focused on lowering their quantity.

In self-attack disorders, experiments are testing increasing regulatory T-cells so the organism is not being harmed. A similar approach could also be effective in minimizing the risks of transplanted organ failure.

Pioneering Studies

Professor Sakaguchi, from Osaka University, conducted tests on rodents that had their immune gland extracted, leading to self-attack conditions.

He showed that injecting defense cells from healthy animals could stop the illness—suggesting there was a mechanism for blocking immune cells from harming the host.

Mary Brunkow, from the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an inherited immune disorder in rodents and humans that led to the discovery of a gene vital for how regulatory T-cells operate.

"Their pioneering work has revealed how the body's defenses is controlled by regulatory T cells, preventing it from mistakenly attacking the body's own tissues," commented a leading physiology expert.

"The work is a striking example of how basic biological research can have far-reaching consequences for public health."